| Literature DB >> 26517532 |
R Wu1,2, H Chen1,3, J Ma1,2, Q He1,2, Q Huang4, Q Liu5, M Li4, Z Yuan1,2,3.
Abstract
Oxidative stress is a major cause of sporadic Parkinson's disease (PD). Here, we demonstrated that c-Abl plays an important role in oxidative stress-induced neuronal cell death. C-Abl, a nonreceptor tyrosine kinase, was activated in an 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine hydrochloride (MPTP)-induced acute PD model. Conditional knockout of c-Abl in neurons or treatment of mice with STI571, a c-Abl family kinase inhibitor, reduced the loss of dopaminergic neurons and ameliorated the locomotive defects induced by short-term MPTP treatment. By combining the SILAC (stable isotope labeling with amino acids in cell culture) technique with other biochemical methods, we identified p38α as a major substrate of c-Abl both in vitro and in vivo and c-Abl-mediated phosphorylation is critical for the dimerization of p38α. Furthermore, p38α inhibition mitigated the MPTP-induced loss of dopaminergic neurons. Taken together, these data suggested that c-Abl-p38α signaling may represent a therapeutic target for PD.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26517532 PMCID: PMC5072446 DOI: 10.1038/cdd.2015.135
Source DB: PubMed Journal: Cell Death Differ ISSN: 1350-9047 Impact factor: 15.828